BPS3082 Chap.4 Linear and Nonlinear Pharmacokinetics
Linear and Nonlinear Pharmacokinetics
Linear pharmacokinetics produces dose-proportional exposure over a stated range: doubling dose approximately doubles AUC, and dose-normalised concentration-time profiles remain similar. Nonlinearity appears when absorption, metabolism or excretion approaches a limit and an effective pharmacokinetic parameter changes with dose. The direction of departure matters.
Greater-than-proportional AUC is compatible with falling effective clearance as an eliminating pathway saturates, whereas less-than-proportional AUC can indicate limited dissolution, absorption or another input process. These are hypotheses, not pathway diagnoses, so formulation, metabolite, clearance and dose-normalised profile evidence must be used to discriminate them.
Michaelis-Menten kinetics supplies a mechanistic rate model for a capacity-limited pathway. Vmax is an amount-per-time capacity; Km is the concentration at which the rate is half of Vmax. When concentration is much lower than Km, the rate is approximately proportional to concentration. When concentration is much higher than Km, the rate approaches Vmax and rate divided by concentration falls.
That limiting-case reasoning explains why exposure can rise disproportionately even though the pathway's maximum capacity has not changed. This chapter therefore treats every nonlinear result as a sequence: define the axes and dose range, quantify proportionality, identify whether the likely limit concerns input or output, and propose a follow-up observation.
It also separates an AUC-versus-dose plateau from an elimination-rate-versus-concentration plateau, two visually similar ideas with opposite implications. Confidence around exposure estimates and replication matter because one noisy extreme dose should not be mistaken for saturation.
What this chapter covers
- 01
Dose-proportional exposure
- 02
Dose-normalised profiles
- 03
Saturable clearance
- 04
Limited dissolution and absorption
- 05
Vmax and Km
- 06
Michaelis-Menten limiting cases
- 07
Exposure ratios across the dose range
- 08
Input limits versus output saturation
- 09
Dose-normalised profile comparison
- 10
Uncertainty around apparent nonlinearity
Worked example · free
Interpret a capacity-limited rate
- +1Use Rate = Vmax × C /(Km + C).
- +2Rate = 60 × 5 /(5 + 5) = 30 mg/h.
- +2Because concentration equals Km, the rate is half of Vmax.
Key terms
- Linear Pharmacokinetics
- Behaviour where exposure changes in direct proportion to dose across the studied range.
- Nonlinear Pharmacokinetics
- Behaviour where exposure is not dose proportional because a pharmacokinetic parameter changes with dose.
- Vmax
- The maximum rate approached by a saturable process.
- Km
- The concentration at which a Michaelis-Menten rate reaches half of Vmax.
- Dose Normalisation
- Division of concentration or exposure by dose to assess proportionality across regimens.
Linear and Nonlinear Pharmacokinetics FAQ
What does greater-than-proportional AUC suggest?
It suggests effective clearance may be falling as dose rises, which can occur when metabolism or excretion approaches capacity. The curve direction is only a clue: confirm that the doses and AUC values are comparable, examine dose-normalised profiles, and seek pathway evidence before naming a mechanism. State the studied range because the same compound may appear linear at lower doses.
What can cause less-than-proportional exposure?
Limited dissolution, absorption or another input process can prevent the full dose from reaching systemic circulation. Formulation observations, recovered material, bioavailability information and dose-normalised profiles help separate input limitation from elimination behaviour. Do not call a flattening AUC-dose curve saturable clearance without checking which variable is plateauing.
Why is Km not a maximum rate?
Km is a concentration locating the half-capacity point, while Vmax is an amount-per-time maximum rate. At C equal to Km, the pathway operates at half Vmax. Checking units and the low- and high-concentration limits prevents the common error of swapping their roles or claiming that Vmax changes merely because saturation occurs.
Assessment move
Sketch AUC against dose for proportional, greater-than-proportional and less-than-proportional exposure, labelling both axes and the studied range before explaining a mechanism. Beside each curve, write whether the proposed constraint acts on input or output and identify one measurement that could distinguish it.
Then sketch elimination rate against concentration so that an AUC plateau is never confused with a Michaelis-Menten rate plateau. Work examples at concentration equal to Km, far below Km and far above Km; calculate the rate, check units and explain the limiting behaviour in a sentence. Add dose-normalised concentration-time profiles to the drill and describe whether they superimpose, rise or fall with dose.
For short answers, use a four-part structure: quantified observation, plausible process, supporting evidence and remaining limitation. Revisit any answer that calls a drug simply 'linear' or 'nonlinear' without specifying dose range and conditions. Finally, practise rejecting overconfident explanations based on one extreme value by asking whether uncertainty, replication or formulation evidence supports the apparent departure.
Create a comparison table with dose ratio, AUC ratio and dose-normalised AUC for several invented pairs, then classify each pattern before considering mechanism. Vary one feature at a time: a formulation dissolution limit, a saturable eliminating pathway or a dose range entirely below Km. Predict how each change affects the AUC-dose graph and concentration-time shape.
End by checking whether an alternative explanation remains plausible and naming a concrete measurement that would discriminate input limitation from reduced effective clearance. This keeps the inference tied to observable evidence.
